TILT Biotherapeutics Funding: $78M Raised, Series B (2025)
TILT Biotherapeutics is based in Helsinki, Finland. It has raised $78M in total funding. Latest round: Series B.
TILT Biotherapeutics funding overview
TILT Biotherapeutics is based in Helsinki, Finland. TILT Biotherapeutics has raised $78M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in May 2025. The round record for TILT Biotherapeutics runs through 2025; nothing later has been disclosed. Investors on record include European Innovation Council (EIC) Fund, Lifeline Ventures, Finnish Industry Investment (TESI), Stephen Industries Inc Oy, Springvest, Business Finland and 1 others. 7 distinct backers are named across the disclosed rounds.
TILT Biotherapeutics at a glance
Total raised
$78M
Latest round
Series B
Latest round date
May 2025
Headquarters
Helsinki, Finland
Notable investors
European Innovation Council (EIC) Fund, Lifeline Ventures, Finnish Industry Investment (TESI), Stephen Industries Inc Oy, Springvest, Business Finland, U.S. Department of Defense
Frequently asked about TILT Biotherapeutics funding
How much has TILT Biotherapeutics raised?
TILT Biotherapeutics has raised $78M in total disclosed funding across the rounds on record.
Who has invested in TILT Biotherapeutics?
European Innovation Council (EIC) Fund, Lifeline Ventures, Finnish Industry Investment (TESI), Stephen Industries Inc Oy, Springvest, Business Finland are named among the investors backing TILT Biotherapeutics.
What was the latest TILT Biotherapeutics funding round?
The most recent disclosed round is a Series B, announced in May 2025.
Where is TILT Biotherapeutics based?
TILT Biotherapeutics is based in Helsinki, Finland.
When did TILT Biotherapeutics last raise?
The last disclosed TILT Biotherapeutics round closed in May 2025 at Series B.
Totals shown for TILT Biotherapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Helsinki and the investors behind them below.
